Biological and clinical evidence for somatic mutations in BRCA1 and BRCA2 as predictive markers for olaparib response in high-grade serous ovarian cancers in the maintenance setting (Q41279420)
Jump to navigation
Jump to search
scientific article published on 4 May 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Biological and clinical evidence for somatic mutations in BRCA1 and BRCA2 as predictive markers for olaparib response in high-grade serous ovarian cancers in the maintenance setting |
scientific article published on 4 May 2017 |
Statements
1 reference
Biological and clinical evidence for somatic mutations in BRCA1 and BRCA2 as predictive markers for olaparib response in high-grade serous ovarian cancers in the maintenance setting (English)
1 reference
Brian A Dougherty
1 reference
Zhongwu Lai
1 reference
Darren R Hodgson
1 reference
Maria C M Orr
1 reference
Matthew Hawryluk
1 reference
James Sun
1 reference
Roman Yelensky
1 reference
Stuart K Spencer
1 reference
Jane D Robertson
1 reference
Tony W Ho
1 reference
Anitra Fielding
1 reference
Jonathan A Ledermann
1 reference
J Carl Barrett
1 reference
Identifiers
1 reference